METHODS FOR OBTAINING ANTI-RETROVIRAL AGENTS

The present invention relates to providing novel therapeutics for treating retro-viral infection- Such therapeutics involve the inhibition of debranching enzyme. Thus, the present provides methods of screening for inhibitors of debranching enzyme and interaction with other molecules as useful target...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	MENEES, THOMAS, M
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to providing novel therapeutics for treating retro-viral infection- Such therapeutics involve the inhibition of debranching enzyme. Thus, the present provides methods of screening for inhibitors of debranching enzyme and interaction with other molecules as useful target for pharmacological manipulation in the treatment of retroviral associated conditions. La présente invention a trait à la fourniture de nouvelles thérapies pour le traitement d'infection rétrovirale. De telles thérapies comprennent l'inhibition de la déramification d'enzyme. Ainsi, la présente invention fournit des procédés de criblage pour des inhibiteurs de déramification d'enzyme et l'interaction avec d'autres molécules en tant que cibles pour la manipulation pharmacologique dans le traitement de conditions associées aux rétrovirus.